A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).
暂无分享,去创建一个
U. Dafni | J. Kerst | A. Sobrero | N. I. Cherny | C. C. Zielinski | E. D. Vries | Richard Sullivan | M. Piccart